Photon Therapeutics Launches the PhotonUVC Vet at London Vet Show
Five Amazing Seconds: UVC Light to Treat Corneal Infections
PhotonUVC Vet, a revolutionary new veterinary non-contact device which treats corneal infections in just five seconds, is set to launch at London Vet Show 2024.
The patented PhotonUVC Vet from Photon Therapeutics is a non-contact five second treatment which emits low dose UVC light at a targeted area, deactivating infecting organisms while being safe to host tissues. With corneal infections a leading cause of blindness in humans and pets, this easy-to-use device is simple, safe and effective.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase –5 Amazing Seconds – A New Transformative Treatment for Corneal Infections – on Thursday 14th November at 3pm.
Attendees will:
- Understand the science behind the PhotonUVC Vet device and how it treats corneal infections in just five seconds.
- Learn how this technological discovery will transform their and their practices approach to eye infections
- Understand how this can optimise outcomes and eliminate owner compliance errors with one treatment, given at the time of presentation of a pet in the practice.
Photon Therapeutics will be at Stand E30 and hosting a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November. The CPD presentation 5 Amazing Seconds – A New Transformative Treatment for Corneal Infections – will take place at Exhibitor Show Case Theatre 3 on Thursday 14th November at 3pm.
Photon Therapeutics was recently recognised as the winner of the Innovation Session, ESCRS iNovation® Day in Barcelona, which asked attendees, ‘Which of the following emerging technologies will have the biggest potential impact on ophthalmic practices and patients in the near future?’.
Photon Therapeutics is a multinational collaborative company drawing on the expertise of pioneers in ophthalmic research and clinical science.
